Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic...
Main Authors: | Andrew C. Peterson, Chiang-shan R. Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2018.00127/full |
Similar Items
-
Autophagy-Based Hypothesis on the Role of Brain Catecholamine Response During Stress
by: Fiona Limanaqi, et al.
Published: (2020-09-01) -
Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys
by: Gunasingh Jeyaraj Masilamoni, et al.
Published: (2017-04-01) -
Altered Extended Locus Coeruleus and Ventral Tegmental Area Networks in Boys with Autism Spectrum Disorders: A Resting-State Functional Connectivity Study
by: Huang Y, et al.
Published: (2021-04-01) -
Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?
by: Yadollah Ranjbar-Slamloo, et al.
Published: (2020-01-01) -
Sequential loss of LC noradrenergic and dopaminergic neurons results in a correlation of dopaminergic neuronal number to striatal dopamine concentration
by: Patricia eSzot, et al.
Published: (2012-10-01)